PRJNA840851
Anthelmintic Potential of Aspartic Proteases Inhibitors
This study aims to evaluate repurposing of aspartic protease inhibitors (APIs) (FDA-approved HIV protease inhibitors) against adult filarial worms (Brugia spp.) as potential macrofilaricides.